CClinicalTrials.gg
RecruitingNCT06987019CSUpdated Sep 30, 2026

Reliability and Validity of Continuous Inter-limb Stability

An interventional study of 3D motion capture, wearable devices, and functional outcome measures in Amputation, Lower Limb, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

To date, there is no valid and reliable measure of continuous inter-limb stability available to healthcare teams treating people with lower limb loss. Determining these characteristics of this parameter for this population is important because superior stability has been linked to increased physical activity and strength in similar populations, making it a potential vital contributor to mobility improvement of Veterans with limb loss. It is also crucial that healthcare providers can easily measure continuous stability in the clinic instead of relying on expensive laboratory equipment. The overall goals of this study are to determine the reliability and validity of continuous inter-limb stability of Veterans with lower limb loss and determine if this parameter can be captured using accessible wearable technology. Consequently, clinicians can improve continuous stability through proper rehabilitation to positively impact the functional mobility and overall quality of life of Veterans with lower limb loss.

Read the detailed description

There is currently no valid or reliable biomechanical variable available to objectively measure the continuous stability of Veterans with lower limb loss. However, continuous inter-limb stability represents a potential target to improve whole-body dynamics, as it is an important measure of functional mobility in individuals with lower limb loss. Determining the reliability and validity of this measure is critical for limb loss care teams since these features are fundamental to interpretability and assessment of this parameter. Unlike traditional clinical assessments of stability that focus on the time of task execution, Relative Phase (RP) analysis, which is a novel methodology that can be used to evaluate continuous stability, uses both space and time within one outcome variable. While previous literature supports the use of continuous stability for mobility challenged populations, such as individuals with limb loss, it has yet to be shown reliable and valid for such populations. Therefore, the first aim of this study is to identify the reliability and validity of continuous inter-limb stability in individuals with transtibial limb loss (TLL) using RP analysis. For this parameter to be used clinically, it is vital to provide rehabilitation specialists the ability to assess continuous stability within the clinical setting. To date, this factor of functional mobility has only been evaluated using 3-dimensional (3-D) motion capture, which is costly and inaccessible to most rehabilitation clinics. Therefore, the second aim of this study is to identify the strength of the association between wearable technology (using inertial measurement units) and 3-D motion capture system for evaluation of continuous interlimb stability of individuals with TLL. The central hypothesis is that continuous stability evaluated using RP analysis will be a reliable and valid measure of functional mobility for Veterans with TLL and that data captured via wearable technology will be strongly associated with 3-D analysis. Twenty Veterans with TLL will be recruited and enrolled via the Prosthetic or Physical Medicine Departments at Veterans Affairs New York Harbor Healthcare System, where all data collection will occur. To measure test re-test reliability, participants will undergo 3 sessions of 3-D gait analysis while walking at a moderate speed (1.3m/s) until 15 walking cycles are captured, with 1 day between sessions. RP analysis will be used to identify the continuous inter-limb stability of gait patterns. Participants will be fit with wearable technology and data will be collected concurrently. To measure convergent validity, participants will perform functional outcome measures including the Timed Up and Go test, 6 Minute Walk Test, Hill and Stair Assessment Indexes, and Amputee Mobility Predictor. Data from 40 participants are required to appropriately power the analysis of convergent validity. To achieve this power, data from 20 participants collected during a previously funded Department of Defense study will be leveraged and added to the data of the 20 participants collected during the proposed study. This is possible due to identical data collection techniques in both studies. To assess the level of agreement between the data obtained from the 3 sessions, Intraclass Correlation Coefficients will be calculated for each variable, in addition to Cohen's kappa statistics and Pearson correlation coefficients. To assess convergent validity, Pearson and Spearman rank correlation coefficients will quantify the strength and direction of the relationships between the outcome measures and continuous stability. Substantiating the use of continuous stability in Veterans with TLL will afford healthcare providers information necessary to accurately detect and appropriately address stability deficiencies, which is critical since superior stability is linked to increased physical activity leading to an enhanced overall quality of life of Veterans with limb loss. Verifying the reliability and validity of this parameter will lead to its confident application for future studies focused on effectiveness, optimization, and rehabilitation.

02

Conditions studied

  • Amputation, Lower Limb

Keywords

  • Transtibial amputation
  • Gait evaluation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any individual with unilateral transtibial limb loss
  • A well-fitting prosthesis (as determined by a board-certified prosthetist through standardized prosthetic guidelines) for a minimum of one month
  • Able to achieve a "Level 6 - Modified Independence" score on the Functional Independence Measure (FIM) for 2 mobility items (locomotion and transfers)

Exclusion criteria

Exclusion Criteria:

  • Individuals with active wounds/ulcers or significant musculoskeletal comorbidities on their intact limb that would impair ability to participate in biomechanical evaluations
  • Any comorbidity that results in rapid limb volume changes (i.e., end stage renal disease with dialysis)
  • A poorly fitting socket
  • Cognitive deficit(s) or mental pathology (e.g., dementia, amnesia) that would prevent the participant from understanding and following directions and limit the participant's ability to participate fully in the study
  • Women who are pregnant or who plan to become pregnant during their participation in study activities
  • Functional Independence Measure (FIM) scores less than Level 6 for locomotion and transfers
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Reliability and Validity

    Reliability and Validity of Inter-limb Stability using 3D motion capture, functional outcome measures, and wearable devices

    Other: 3D motion capture, wearable devices, and functional outcome measures

Interventions

  • Other3D motion capture, wearable devices, and functional outcome measures

    Gait evaluation, Hill and Stair Assessment Indices, 6 minute walk test, AMPPro, Timed Up and Go

05

What researchers measure

Primary outcomes

  1. Reliability of Continuous Inter-limb Stability

    Reliability will be evaluated using Deviation Phase using Relative Phase Analysis. Deviation Phase measures the continuous stability of two oscillating segments throughout a cyclical movement. Relative Phase Analysis is a dynamical systems based methodology that is used to calculated the continuous stability of a movement, such as walking. Deviation Phase ranges from 0-180 degrees, with a lower value indicating better organization of the neuromuscular system.

    Time frame: 3 times at visits 2-4 (once per visit) (will occur within 1 week)

  2. Convergent Validity of Continuous Inter-limb Stability - TUG

    The TUG measures physical mobility in individuals with lower limb loss. This measures the time it takes for an individual to stand up from a standard arm chair, walk a distance of 10 feet, turn, walk back to the chair, and sit down. This is measured in time (seconds).

    Time frame: Once at visit 2 of 4 (Baseline)

  3. Convergent Validity of Continuous Inter-limb Stability - 6MWT

    The 6MWT measure function and endurance. This test measures the distance an individual can walk in 6 minutes without help. This is measured in meters.

    Time frame: Once at visit 2 of 4 (Baseline)

  4. Convergent Validity of Continuous Inter-limb Stability - SAI

    The SAI is a graded qualitative scale on how an individual with lower limb amputation negotiates up and down a staircase. This is measured on a scale of 0-13.

    Time frame: Once at visit 2 of 4 (Baseline)

  5. Convergent Validity of Continuous Inter-limb Stability - HAI

    The HAI is a graded qualitative scale on how an individual with lower limb amputation negotiates up and down a ramp. This is measured on a scale from 0-11.

    Time frame: Once at visit 2 of 4 (Baseline)

  6. Convergent Validity of Continuous Inter-limb Stability - AMPPro

    The AMPPro is a 21 item instrument designed to measure basic prosthetic mobility of individuals with lower extremity amputation. This is scored from 0-47.

    Time frame: Once at visit 2 of 4 (Baseline)

Secondary outcomes

  1. Strength of association between wearable technology and 3D motion capture to measure inter-limb stability

    Correlation between IMUs and Motion Capture. Xsens IMUs consist of 3 measurement sensor categories: accelerometer, gyroscope, and magnetometer, with measurements of all 3 axes. The accelerometer provides linear acceleration of the deice. The Gyroscope measures the angular rate and is then integrated to determine the angle of the sensor. The magnetometer detects magnetic field, use as an external reference frame. The 3 signals combine to produce a sensor coordinate system, while the signal variety eliminates drift effects commonly found in gyroscopic measurements.

    Time frame: 3 times at visits 2-4 (once per visit) (will occur within 1 week)

06

Study locations

1 of 1 sites recruiting
  • VA NY Harbor Healthcare System, New York, NY
    New York, New York 10010-5011, United States
    • Alexis Sidiropoulos, PhD · Contact · alexis.sidiropoulos@va.gov · (212) 686-7500
    • Alexis Sidiropoulos, PhD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will be stored in a curated data repository that makes the data underlying scientific publications discoverable, freely usable, and citable, while promoting openly available research integrated with scholarly literature.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06987019
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
May 23, 2025
Start date
Apr 1, 2025
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

Alexis Sidiropoulos, PhD
Contact
alexis.sidiropoulos@va.gov
(212) 686-7500
Jason Maikos, PhD
Contact
Jason.Maikos@va.gov
(212) 686-7500 ext. 7482
Alexis Sidiropoulos, PhD
principal investigator · VA NY Harbor Healthcare System, New York, NY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion